STRUCTURE-ACTIVITY-RELATIONSHIPS OF SEROTONIN TRANSPORT - RELEVANCE TO NONTRICYCLIC ANTIDEPRESSANT INTERACTIONS

被引:21
作者
CHANG, ASS
CHANG, SM
STARNES, DM
机构
[1] The Center for Biotechnology, Baylor College of Medicine, The Woodlands, TX 77381
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1993年 / 247卷 / 03期
关键词
MOLECULAR MODELING; NEUROTRANSMITTER TRANSPORT; TRANSPORT PHARMACOPHORE; SPECIFIC SEROTONIN TRANSPORT INHIBITORS;
D O I
10.1016/0922-4106(93)90191-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A transfectant cell model was used to examine the structure-activity relationships of serotonin (5-hydroxytryptamine, 5-HT) transport. The findings suggest that 5-HT interacts largely with nonpolar and sterically-confining environments on the transport system, and that a particular spatial coordination of the amino and phenyl groups (separated by an alkyl backbone) is important for transport interaction. Molecular modelling analyses revealed that this motif is also present in the structures of several nontricyclic antidepressants and specific inhibitors of 5-HT transport, as well as adrenergic agents which also possess 5-HT transport-inhibitory activities. While this amino-phenyl coordination motif seems to be a necessary structural requisite for transport interaction, and therefore likely to be part of the transport pharmacophore, additional phenyl rings present in some of the nontricyclic antidepressants may help to account for their relatively higher affinities in 5-HT transport interaction.
引用
收藏
页码:239 / 248
页数:10
相关论文
共 33 条
  • [1] RELATIVE ACTIVITIES ON AND UPTAKE BY HUMAN BLOOD-PLATELETS OF 5-HYDROXYTRYPTAMINE AND SEVERAL ANALOGS
    BORN, GVR
    JUENGJAROEN, K
    MICHAL, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (01) : 117 - +
  • [2] BURLEY SK, 1988, ADV PROTEIN CHEM, V39, P125
  • [3] CHARACTERIZATION OF A GENETICALLY RECONSTITUTED HIGH-AFFINITY SYSTEM FOR SEROTONIN TRANSPORT
    CHANG, ASS
    FRNKA, JV
    CHEN, D
    LAM, DMK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (23) : 9611 - 9615
  • [4] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [5] DAMATO RJ, 1987, J PHARMACOL EXP THER, V242, P364
  • [6] ENNA SJ, 1987, HDB PSYCHOPHARMACOL, V19, P609
  • [7] ENNA SJ, 1986, RECEPTOR BINDING DRU, P409
  • [8] FRNKA JV, 1991, J PHARMACOL EXP THER, V256, P734
  • [9] CHARACTERIZATION OF [H-3] PAROXETINE BINDING TO RAT CORTICAL MEMBRANES
    HABERT, E
    GRAHAM, D
    TAHRAOUI, L
    CLAUSTRE, Y
    LANGER, SZ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1985, 118 (1-2) : 107 - 114
  • [10] Horn A S, 1978, Ann N Y Acad Sci, V305, P128, DOI 10.1111/j.1749-6632.1978.tb31516.x